Krystal Biotech (KRYS) Short-term Investments (2018 - 2026)

Krystal Biotech (KRYS) has 9 years of Short-term Investments data on file, last reported at $322.1 million in Q1 2026.

• For the quarter ending Q1 2026, Short-term Investments rose 4.55% year-over-year to $322.1 million; the trailing twelve-month figure through Mar 2026 stood at $322.1 million (up 4.55% YoY), and the FY2025 full-year result was $331.5 million, up 31.2% from the prior year.
• Short-term Investments retreated to $322.1 million in Q1 2026, from $331.5 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $338.5 million in Q3 2025 to a low of $165.3 million in Q1 2022.
• A 5-year average of $238.8 million and a median of $213.8 million in 2024 frame the typical range for Short-term Investments.
• Across the five-year window, Short-term Investments surged 13147.52% in 2022 and dropped 19.98% in 2023, its largest moves.
• Tracing KRYS's Short-term Investments over 5 years: stood at $217.3 million in 2022, then retreated by 19.98% to $173.8 million in 2023, then jumped by 45.33% to $252.7 million in 2024, then surged by 31.2% to $331.5 million in 2025, then dropped by 2.83% to $322.1 million in 2026.
• Business Quant data shows KRYS's Short-term Investments at $322.1 million in Q1 2026, $331.5 million in Q4 2025, and $338.5 million in Q3 2025.